Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2005

View Archived Issues

Nautilus achieves milestone in Serono hGH collaboration

PTC Therapeutics receives award to support development of PTC-124

Codevelopment agreement for tramadol hydrochloride in Japan

New phase I/II study of AP-12009

Drug discovery milestone in Astex's collaboration with Boehringer Ingelheim

Completion of treatment in Cubicin endocarditis/bacteremia study

Aerogen receives fast track status for aerosolized amikacin

GenVec expands testing of AdPEDF for AMD

Enrollment begins in phase III study of ICA-17043 for sickle cell disease

Enrollment completed in ATLAS study of Taxus Liberte stent

FDA approves amendments to ARISE study of AGI-1067

PhytoMedical enters agreement for animal studies of BDC-03

Update on the antitumor effects of autologous Xcellerated T-cells in hematological malignancies

Clinical evidence supports the use of oral fumarate BG-12 in psoriasis

Rofecoxib increases blood pressure in hypertensive patients with type 2 diabetes

Enablex launched in U.S.

Atacand approved for treatment of heart failure

Positive opinion in Europe for Invirase 500 mg

CVT-5440: a selective, high affinity adenosine A2B receptor antagonist for asthma therapy

Entecavir reported effective against recurrent HBV viremia in HIV/HBV coinfection

Novel 5-HT/noradrenaline reuptake inhibitors claimed by Pfizer

Roche presents tetraazaphenalene derivatives with anticancer activity

Two novel series of PDE7 inhibitors imparted by Daiichi Suntory

Lysophospholipid receptor ligands disclosed by Novartis

Scientists at Schering AG describe new VEGFR-2 inhibitors and their use

Novel tachykinin antagonists developed by Fujisawa

New steroid compounds for use in X-ray contrast media claimed by Fuji Photo Film